Teplizumab Could Delay Diagnosis of Type 1 Diabetes

FRIDAY, March 12, 2021 -- A single course of teplizumab treatment delays progression to type 1 diabetes (T1D) and improves beta cell function in high-risk individuals, according to a study published in the March 3 issue of Science Translational...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news